Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Centessa Pharmaceuticals PlcADS | 19,963,157 | 19,963,157 | 0 | $319.21M | $334.38M | 63.20% | +$15.17M |
| Newamsterdam Pharma Company ORDINARY SHARES | 2,869,565 | 2,869,565 | 0 | $47.63M | $73.75M | 13.94% | +$26.11M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 7,464,572 | 7,464,572 | 0 | $134.96M | $60.61M | 11.46% | -$74.35M |
| Rapt Therapeutics Inc | 0 | 22,352,000 | +22,352,000 | $0 | $35.32M | 6.68% | +$35.32M |
| Aura Biosciences, Inc.(AURA) | 3,039,892 | 3,039,892 | 0 | $27.09M | $24.99M | 4.72% | -$2.10M |